Komori
Nihon Parkerizing (4095) · FactR&D expenditure increased to ¥2,754 million

Total R&D investment of ¥2,303 million

First written in FY2017. . Latest entry: FY2026.

31entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2017 – FY20262017: 320172018: 320182019: 420192020: 420202021: 320212022: 420222023: 420232024: 320242025: 220252026: 12026
Same theme, other companies
Continued company-wide R&D activities and resource investmentA theme 202 companies write about · 0 as a headwind · 215 as a tailwind

92 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 217 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026R&D expenditure increased to ¥2,754 millionAnnual report

    「During the consolidated fiscal year, we invested ¥2,754 million in total research and development expenses.」

    Research and development expenses increased from ¥2,185 million in the previous fiscal year to ¥2,754 million.
  2. FY2026-H1Disclosed interim research and development expenses of ¥1,407 millionAnnual report

    「Total research and development expenses for the interim consolidated accounting period amounted to ¥1,407 million.」

    Research and development expenses for the interim consolidated accounting period were ¥1,407 million, up from ¥1,021 million in the same period of the previous year.
  3. FY2025Research and development expenses increased to ¥2,185 millionAnnual report

    「During the consolidated fiscal year, we invested ¥2,185 million in total research and development expenses.」

    Research and development expenses increased from ¥1,982 million in the previous fiscal year to ¥2,185 million.
  4. FY2025-H1Disclosed interim research and development expenses of ¥1,021 millionAnnual report

    「Total research and development expenses for the interim consolidated accounting period amounted to ¥1,021 million.」

    Research and development expenses for the interim consolidated accounting period were ¥1,021 million, up from ¥975 million in the same period of the previous year.
  5. FY2024R&D expenditure of ¥1,982 million disclosedAnnual report

    「During the consolidated fiscal year, we invested ¥1,982 million in total research and development expenses.」

    Research and development expenses for the fiscal year ended March 2024 were ¥1,982 million, up from ¥1,914 million in the previous fiscal year.
  6. FY2024-Q3Third-quarter R&D expenditure of ¥1,471 million disclosedAnnual report

    「R&D expenditure for the third quarter of the current consolidated cumulative period totaled ¥1,471 million.」

    The company disclosed R&D expenditure of ¥1,471 million for the third-quarter consolidated cumulative period. It stated that there had been no significant changes in the status of R&D activities.
  7. FY2024-Q2Second-quarter R&D expenditure of ¥975 million disclosedAnnual report

    「R&D expenditure for the second quarter of the current consolidated cumulative period totaled ¥975 million.」

    R&D expenditure for the second-quarter cumulative period amounted to ¥975 million.
  8. FY2024-Q1First-quarter R&D expenditure of ¥481 million disclosedAnnual report

    「R&D expenditure for the first quarter of the current consolidated cumulative period totaled ¥481 million.」

    The company disclosed R&D expenditure of ¥481 million for the first quarter of the consolidated cumulative period. It stated that there had been no significant changes in the status of R&D activities.
  9. FY2023R&D expenditure of ¥1,914 million disclosedAnnual report

    「During the consolidated fiscal year, we spent ¥1,914 million on R&D in total.」

    R&D expenditure was ¥1,914 million for the current fiscal year, down from ¥2,011 million in the previous fiscal year.
  10. FY2023-Q3Third-quarter R&D expenditure of ¥1,443 million disclosedAnnual report

    「R&D expenditure for the third quarter of the current consolidated cumulative period totaled ¥1,443 million.」

    The company disclosed R&D expenditure of ¥1,443 million for the third-quarter consolidated cumulative period. It stated that there had been no significant changes in the status of R&D activities.
  11. FY2023-Q2Second-quarter R&D expenditure of ¥951 million disclosedAnnual report

    「R&D expenditure for the second quarter of the current consolidated cumulative period totaled ¥951 million.」

    The company disclosed R&D expenditure of ¥951 million for the second-quarter cumulative period. It stated that there had been no significant changes in the status of R&D activities.
  12. FY2023-Q1First-quarter R&D expenditure of ¥476 million disclosedAnnual report

    「R&D expenditure for the first quarter of the current consolidated cumulative period totaled ¥476 million.」

    The company disclosed R&D expenditure of ¥476 million for the first quarter of the consolidated cumulative period. It stated that there had been no significant changes in the status of R&D activities.
  13. FY2022R&D expenditure of ¥2,011 million disclosedAnnual report

    「During the consolidated fiscal year, we spent ¥2,011 million on R&D in total.」

    R&D expenditure for the consolidated fiscal year amounted to ¥2,011 million.
  14. FY2022-Q3Third-quarter R&D expenditure of ¥1,532 million disclosedAnnual report

    「R&D expenditure for the third quarter of the current consolidated cumulative period totaled ¥1,532 million.」

    The company disclosed R&D expenditure of ¥1,532 million for the third-quarter consolidated cumulative period. It stated that there had been no significant changes in the status of R&D activities.
  15. FY2022-Q2Second-quarter R&D expenditure of ¥1,023 million disclosedAnnual report

    「R&D expenditure for the second quarter of the current consolidated cumulative period totaled ¥1,023 million.」

    The company disclosed R&D expenditure of ¥1,023 million for the second-quarter cumulative period.
  16. FY2022-Q1First-quarter R&D expenditure of ¥553 million disclosedAnnual report

    「R&D expenditure for the first quarter of the current consolidated cumulative period totaled ¥553 million.」

    The company disclosed R&D expenditure of ¥553 million for the first quarter of the consolidated cumulative period.
  17. FY2021-Q3Third-quarter R&D expenditure of ¥1,475 million disclosedAnnual report

    「R&D expenditure for the third quarter of the current consolidated cumulative period totaled ¥1,475 million.」

    The company disclosed R&D expenditure of ¥1,475 million for the third quarter of the consolidated cumulative period.
  18. FY2021-Q2Second-quarter R&D expenditure disclosedAnnual report

    「R&D expenditure for the second quarter of the current consolidated cumulative period totaled ¥970 million.」

    R&D expenditure for the second quarter of the consolidated cumulative period amounted to ¥970 million.
  19. FY2021-Q1First-quarter R&D expenditure disclosedAnnual report

    「R&D expenditure for the first quarter of the current consolidated cumulative period totaled ¥504 million.」

    The company disclosed R&D expenditure of ¥504 million for the first quarter of the consolidated cumulative period.
  20. FY2020R&D expenditure of ¥2,220 million disclosedAnnual report

    「During the consolidated fiscal year, we spent ¥2,220 million on R&D in total.」

    R&D expenditure for the consolidated fiscal year amounted to ¥2,220 million.
  21. FY2020-Q3Third-quarter R&D expenditure disclosedAnnual report

    「R&D expenditure for the third quarter of the current consolidated cumulative period totaled ¥1,680 million.」

    The company disclosed R&D expenditure of ¥1,680 million for the third quarter of the 135th fiscal year consolidated cumulative period.
  22. FY2020-Q2Second-quarter R&D expenditure disclosedAnnual report

    「R&D expenditure for the second quarter of the current consolidated cumulative period totaled ¥1,110 million.」

    The company disclosed R&D expenditure of ¥1,110 million for the second quarter of the 135th fiscal year consolidated cumulative period.
  23. FY2020-Q1First-quarter R&D expenditure disclosedAnnual report

    「R&D expenditure for the first quarter of the current consolidated cumulative period totaled ¥542 million.」

    The company disclosed R&D expenditure of ¥542 million for the first quarter of the 135th fiscal year consolidated cumulative period.
  24. FY2019R&D expenditure of ¥2,154 million disclosedAnnual report

    「During the consolidated fiscal year, we spent ¥2,154 million on R&D in total.」

    R&D expenditure for the consolidated fiscal year amounted to ¥2,154 million.
  25. FY2019-Q3Third-quarter R&D expenditure disclosedAnnual report

    「R&D expenditure for the third quarter of the current consolidated cumulative period totaled ¥1,604 million.」

    The company disclosed R&D expenditure of ¥1,604 million for the third quarter of the consolidated cumulative period.
  26. FY2019-Q2Second-quarter R&D expenditure disclosedAnnual report

    「R&D expenditure for the second quarter of the current consolidated cumulative period totaled ¥1,044 million.」

    The company disclosed R&D expenditure of ¥1,044 million for the second quarter of the consolidated cumulative period.
  27. FY2019-Q1First-quarter R&D expenditure disclosedAnnual report

    「R&D expenditure for the first quarter of the current consolidated cumulative period totaled ¥520 million.」

    The company disclosed R&D expenditure of ¥520 million for the first quarter of the 134th fiscal year consolidated cumulative period.
  28. FY2018-Q3Third-quarter R&D expenditure disclosedAnnual report

    「R&D expenditure for the third quarter of the current consolidated cumulative period totaled ¥1,728 million.」

    The company disclosed R&D expenditure of ¥1,728 million for the third quarter of the consolidated cumulative period.
  29. FY2018-Q2Second-quarter R&D expenditure disclosedAnnual report

    「R&D expenditure for the second quarter of the current consolidated cumulative period totaled ¥1,150 million.」

    The company disclosed R&D expenditure of ¥1,150 million for the second quarter of the consolidated cumulative period.
  30. FY2018-Q1First-quarter R&D expenditure disclosedAnnual report

    「R&D expenditure for the first quarter of the current consolidated cumulative period totaled ¥570 million.」

    The company disclosed R&D expenditure of ¥570 million for the first quarter of the consolidated cumulative period.
  31. FY2017First statedAnnual report

    「During the consolidated fiscal year, we spent ¥2,303 million on R&D in total.」

    The company disclosed R&D expenditure of ¥2,303 million for the consolidated fiscal year.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Nihon Parkerizing yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Total R&D investment of ¥2,303 million | NIHON PARKERIZING CO.,LTD. (4095) | Komori